SEC Form 4 · accession 0000899243-18-000215
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Elsbree
Director
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 2:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 1, 2018 | A | 9,708 | A | — | — | Common Stock | 9,708 | 9,708 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Program and vest on January 1, 2019.